A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail ...

A recent paper in Nature Biotechnology examines problems and solutions for antibody-based therapies for solid pancreatic ...

Early results reveal how a single‑cell spatial platform maps stromal barriers that limit antibody delivery and target engagement in human solid tumors.

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

Upon administration, VLPs are uptake by APC, like dendritic cells. VLPs can be presented by MHC-I or MHC-II, which are recognized by CD8+ and CD4+ T cells, respectively. For cellular response, CD8+ ...

Researchers created proteins that fold into logic-based shapes, letting therapies target disease sites precisely and cut off-target effects. (Nanowerk News) Targeted drug delivery is a powerful and ...

A £1 million research project led by the University of Sheffield is developing a new generation of “smart” drug delivery vehicles that could deliver chemotherapy directly to post-surgical sites in ...

Therapies that are sensitive to multiple biomarkers could allow medicines to reach only the areas of the body where they are needed. The diagram above shows three theoretical biomarkers that are ...